STOCK TITAN

Harrow: Daniel Kaufman reports 5.04% stake

Harrow, Inc. Schedule 13G reports that Daniel Kaufman beneficially owns 1,878,000 shares of Common Stock, representing 5.04% as of 03/10/2026.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Harrow, Inc. Schedule 13G reports that Daniel Kaufman beneficially owns 1,878,000 shares of Common Stock, representing 5.04% as of 03/10/2026.

The filing lists Kaufman’s sole voting and dispositive power over the 1,878,000 shares. The address and CUSIP are provided in the disclosure.

Insights

Beneficial owner files passive Schedule 13G showing a >5% stake.

Daniel Kaufman is reported as beneficial owner of 1,878,000 shares with sole voting and dispositive power, representing 5.04% as of 03/10/2026.

Schedule 13G is typically passive reporting; the filing does not state changes to voting agreements or plans. Subsequent filings would show any active purchases or sales.

Holding size is visible; trading implications depend on future disclosures.

The disclosure quantifies a 5.04% beneficial position (1,878,000 shares) and confirms sole vote/dispositive authority for Kaufman as of 03/10/2026.

Market impact or intent is not stated in this excerpt; any change in holdings would be reported in later filings.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Daniel Kaufman report in Harrow (HROW)?

He reports beneficial ownership of 1,878,000 shares. The filing states this equals 5.04% of Harrow's common stock as of 03/10/2026, with sole voting and dispositive power.

What form was filed to disclose Daniel Kaufman’s holdings in HROW?

A Schedule 13G was filed. The Schedule 13G lists passive beneficial ownership and shows Kaufman’s amount, voting/dispositive powers, address, and the issuer CUSIP (415858109).

Does the Schedule 13G indicate Kaufman plans to buy or sell Harrow shares?

No transaction intent is stated in the excerpt. The filing lists current beneficial ownership of 1,878,000 shares and does not describe purchases, sales, or plans to transact.

What voting and dispositive powers does Kaufman have over the shares?

The filing reports sole voting power of 1,878,000 shares and sole dispositive power of 1,878,000 shares, with no shared powers reported in the Schedule 13G.

Where can investors find identifying details from the filing?

The Schedule 13G includes the issuer address (Nashville, TN), the filer’s address (San Juan, Puerto Rico), and the issuer CUSIP 415858109, all shown in the disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Accepted by SEC EDGAR Learn about SEC filing dates





03/10/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Daniel Kaufman
Signature:/s/ Daniel Kaufman
Name/Title:Daniel Kaufman, Individual Investor
Date:03/10/2026
Exhibit Information

None

Keep reading